GLENMEDE TRUST CO NA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 194 filers reported holding HAEMONETICS CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$216,0000.0%1,8810.0%0.00%0.0%
Q4 2019$216,000
-4.0%
1,881
+5.4%
0.00%0.0%
Q3 2019$225,000
+5.6%
1,784
+0.7%
0.00%0.0%
Q2 2019$213,000
+23.8%
1,771
-10.4%
0.00%0.0%
Q1 2019$172,000
-24.2%
1,976
-13.3%
0.00%0.0%
Q4 2018$227,000
+86.1%
2,278
+65.6%
0.00%0.0%
Q2 2018$122,000
+662.5%
1,376
+374.5%
0.00%
Q1 2018$16,0000.0%2900.0%0.00%
Q4 2017$16,000
+166.7%
290
+92.1%
0.00%
Q3 2017$6,000
-14.3%
151
-23.0%
0.00%
Q2 2017$7,0000.0%1960.0%0.00%
Q1 2017$7,000
+600.0%
196
+512.5%
0.00%
Q4 2016$1,000
-75.0%
32
-77.1%
0.00%
Q2 2016$4,000
-42.9%
140
-37.2%
0.00%
Q1 2016$7,000
+75.0%
223
+33.5%
0.00%
Q4 2015$4,0000.0%1670.0%0.00%
Q3 2015$4,0000.0%167
+34.7%
0.00%
Q2 2015$4,0000.0%124
+24.0%
0.00%
Q1 2015$4,000
+33.3%
1000.0%0.00%
Q4 2014$3,0000.0%1000.0%0.00%
Q3 2014$3,000
-62.5%
100
-60.0%
0.00%
Q2 2014$8,000
+100.0%
250
+66.7%
0.00%
Q1 2014$4,000
-33.3%
1500.0%0.00%
Q4 2013$6,000
+20.0%
1500.0%0.00%
Q3 2013$5,000
-16.7%
1500.0%0.00%
Q2 2013$6,000
-98.2%
150
-97.7%
0.00%
-100.0%
Q2 2007$340,0006,4700.05%
Other shareholders
HAEMONETICS CORP shareholders Q2 2013
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders